Service de néphrologie et hypertension

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1681 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | ...
Sous presse
 
The Interprofessional Medication Adherence Program (IMAP) supported patients’ medication adherence during the COVID 19 lockdown in Switzerland
Bandiera Carole, Pasquier Jérôme, Locatelli Isabella, Niquille Anne, Wuerzner Grégoire, Dotta Celio Jennifer, Hachfeld Anna, Wandeler Gilles, Wagner Dorothea, Csajka Chantal et al. dans To what extent medication adherence was impacted by the COVID-19 lockdown in patients included in the Interprofessional Medication Adherence Program (IMAP)?.
[serval:BIB_4D39DAAD5F39]
 
Non-Plasmapheresis Approaches for Managing Severe Renal Thrombotic Microangiopathy: A Report of 7 Cases.
Frimat M., Maanaoui M., Schwotzer N., Lebas C., Lionet A., Dubucquoi S., Gnemmi V., Fakhouri F., Provôt F. American journal of kidney diseases. Peer-reviewed.
[DOI][Pmid][serval:BIB_BE3E28F2CB46]
 
Toward a Restrictive Use of Plasma Exchanges in Thrombotic Microangiopathies.
Frimat M., Schwotzer N., Provôt F., Fakhouri F. Journal of the American Society of Nephrology. Peer-reviewed.
[DOI][Pmid][serval:BIB_B2AACDC31A09]
 
Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis
Halfon Matthieu, Taffé Patrick, Bucher Christian, Haidar Fadi, Huynh-do Uyen, Mani Laila-Yasmin, Schachtner Thomas, Wehmeier Caroline, Venetz Jean-Pierre, Pascual Manuel et al. Kidney International Reports.
[DOI][serval:BIB_D7E82EDAEFE7]
 
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study).
Ostrowska A., Wojciechowska W., Rajzer M., Weber T., Bursztyn M., Persu A., Stergiou G., Kiełbasa G., Chrostowska M., Doumas M. et al. European journal of internal medicine. Peer-reviewed.
[DOI][Pmid][serval:BIB_1DA972F53DB1]
 
Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN.
Roquigny J., Meuleman M.S., El Sissy C., Martins P.V., Meri S., Duval A., Lequintrec M., Fakhouri F., Chauvet S., Frémeaux-Bacchi V. Nephrology, dialysis, transplantation. Peer-reviewed.
[DOI][Pmid][serval:BIB_402F4724821D]
 
Prevalence of hypertension and uncontrolled hypertension after solid organ transplantation: a 5-year follow-up of the Swiss Transplant Cohort Study.
Schwotzer N., Lu Y., Halfon M., Pascual M., Marques-Vidal P., Golshayan D., Wuerzner G., Swiss Transplant Cohort Study Journal of hypertension. Peer-reviewed.
[DOI][Pmid][serval:BIB_4ED1CF31A419]
 
Risk Factors of Asymptomatic Kidney Stone Passage in Adults with Recurrent Kidney Stones.
Stritt K., Fuster D.G., Dhayat N.A., Bonny O., Faller N., Christe A., Taha A., Ochs V., Ortlieb N., Roth B. et al. Clinical journal of the American Society of Nephrology. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46C44592727D]
 
Salt-sensitive hypertension in GR mutant rats is associated with altered plasma polyunsaturated fatty acid levels and aortic vascular reactivity.
Verouti S., Aeschlimann G., Wang Q., Del Olmo D.A., Peyter A.C., Menétrey S., Winter D.V., Odermatt A., Pearce D., Hummler E. et al. Pflugers Archiv. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84772787F782]
2024
 
In remembrance: the life and legacy of George L. Bakris (1952–2024)
Sarafidis Pantelis, Tsioufis Kostas, Burnier Michel, Williams Bryan, Mancia Giuseppe, Weber Thomas, Stergiou George S., 2024/12/31. Blood Pressure, 33 (1).
[DOI][WoS][serval:BIB_4C7C7B456E83]
 
Association of mid-regional pro-adrenomedullin with office and 24-h ambulatory blood pressure in a Swiss general population sample.
Baldwin J., Burnier M., Ponte B., Ackermann D., Pruijm M., Vogt B., Bochud M., 2024/12/01. Journal of hypertension, 42 (12) pp. 2187-2195. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E70AF0F68DC6]
Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
Kjeldsen S.E., Egan B.M., Burnier M., Narkiewicz K., Kreutz R., Mancia G., 2024/12. Blood pressure, 33 (1) p. 2329571. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A45F469F2BCE]
Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study.
Kreutz R., Brunström M., Kjeldsen S.E., Narkiewicz K., Egan B., Burnier M., 2024/12. Blood pressure, 33 (1) p. 2394448. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D5FE14D5AB7]
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.
Halimi J.M., Sarafidis P., Azizi M., Bilo G., Burkard T., Bursztyn M., Camafort M., Chapman N., Cottone S., de Backer T. et al., 2024/12. Blood pressure, 33 (1) p. 2368800. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6A48E2F7305E]
Should treatment of 'elevated' blood pressure, especially in older people, be based on global risk estimation?
Kjeldsen S.E., Brunström M., Burnier M., Egan B., Narkiewicz K., Kreutz R., Mancia G., 2024/12. Blood pressure, 33 (1) p. 2430228. Peer-reviewed.
[DOI][Pmid][serval:BIB_92DD51454229]
 
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).
Wojciechowska W., Rajzer M., Kreutz R., Weber T., Bursztyn M., Persu A., Stergiou G., Parati G., Bilo G., Pac A. et al., 2024/12/01. Journal of hypertension, 42 (12) pp. 2065-2074. Peer-reviewed.
[DOI][Pmid][serval:BIB_428A8450E854]
 
In remembrance: the life and legacy of George L. Bakris (1952-2024).
Sarafidis P.A., Tsioufis K., Burnier M., Williams B., Mancia G., Weber T., Stergiou G.S., European Society of Hypertension and the International Society of Hypertension, 2024/11/01. Journal of hypertension, 42 (11) pp. 2021-2023. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D5DC9AF73122]
Urinary sC5b-9 is Better Linked to Albuminuria Than to Intrarenal Inflammation in Common Kidney Disease.
Kissling S., Schwotzer N., Moser M., Froissart M., Fakhouri F., 2024/11. Kidney international reports, 9 (11) pp. 3335-3337. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B5525807BD4]
 
Reference values for plasma and urine trace elements in a Swiss population-based cohort.
Perrais M., Trächsel B., Lenglet S., Pruijm M., Ponte B., Vogt B., Augsburger M., Rousson V., Bochud M., Thomas A., 2024/10/28. Clinical chemistry and laboratory medicine, 62 (11) pp. 2242-2255. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FF27C8C5A176]
 
Association of High Blood Pressure With Post-Traumatic Stress Disorder in Ukrainian Women Refugees.
Shalimova A., Stoenoiu M.S., Manolache N.G., Cubała W.J., Burnier M., Narkiewicz K., Persu A., 2024/10. Hypertension, 81 (10) pp. e128-e131. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C0D55EB6AE9E]
 
Blocage de l’aldostérone : état des lieux en 2024 [The 2024 landscape of aldosterone blockade]
Zahnd J., Mehier P., Wuerzner G., 2024/09/11. Revue medicale suisse, 20 (886) pp. 1598-1601. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_089E0E4C27D0]
 
Innovation pour les patients avec hypertension artérielle.
Ehret G., Ponte B., Wuerzner G., 2024/09/11. Revue medicale suisse, 20 (886) pp. 1591-1592. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F54B2E29C8D8]
 
Mesures diététiques et facteurs de risque cardiovasculaire : quelles évidences ? [Dietary adaptations and cardiovascular risk factors: what are the evidences ?]
Schreiter-Milcent K., Godio Delay M., Wuerzner G., Gobin N., 2024/09/11. Revue medicale suisse, 20 (886) pp. 1617-1622. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F54DB354A52B]
 
Accelerated hypertension following mavacamten introduction in severe obstructive hypertrophic cardiomyopathy with hypertension: a case report.
Maurizi N., Antiochos P., Muller O., Wuerzner G., Monney P., 2024/09. European heart journal. Case reports, 8 (9) pp. ytae450. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_118CE06BE3E5]
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group.
Nester C.M., Feldman D.L., Burwick R., Cataland S., Chaturvedi S., Cook H.T., Cuker A., Dixon B.P., Fakhouri F., Hingorani S.R. et al., 2024/09. Kidney international, 106 (3) pp. 326-336. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_086023EEA59F]
 
Erworbenes von-Willebrand-Syndrom: Fallbericht und Literaturübersicht [Acquired von Willebrand syndrome: case report and literature review]
Jendly V., Schwotzer N., Voegeli J., Gomez F.J., Kissling S., Alberio L., 2024/09. Praxis, 113 (8) pp. 213-218. Peer-reviewed.
[DOI][Pmid][serval:BIB_FB86AFAB04CD]
 
Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire.
Halimi J.M., Sarafidis P., Azizi M., Bilo G., Burkard T., Bursztyn M., Camafort M., Chapman N., Cottone S., de Backer T. et al., 2024/09/01. Journal of hypertension, 42 (9) pp. 1544-1554. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B6EF6B94F5B]
 
Chronic metabolic acidosis in a patient with diabetes on maintenance haemodialysis: mind the anion gap.
Marecek R., Kissling S., Teso A.D., Vuignier Y., Wojtusciszyn A., 2024/08/10. Lancet, 404 (10452) pp. 570-571. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0D914FB1EC3]
 
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.
Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., de Pinho R.M., Albini F.L., Boivin J.M. et al., 2024/08. European journal of internal medicine, 126 pp. 1-15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_032DCA30DA19]
 
Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome.
Schwotzer N., Fakhouri F., Martins P.V., Delmas Y., Caillard S., Zuber J., Moranne O., Mesnard L., Frémeaux-Bacchi V., El-Sissy C., 2024/08. American journal of kidney diseases, 84 (2) pp. 244-249. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8B36905C32DA]
Poor Physician Adherence to Clinical Guidelines in Hypertension-Time for Physicians to Face Clinical Inertia.
Burnier M., 2024/08/01. JAMA network open, 7 (8) pp. e2426830. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F56742E14A3C]
 
Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies.
Laaboub N., Ranjbar S., Strippoli M.F., Marques-Vidal P., Estoppey-Younes S., Ponte B., Pruijm M., Vogt B., Ansermot N., Crettol S. et al., 2024/08. European journal of nutrition, 63 (5) pp. 1555-1564. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D000B2F7D371]
Intravenous ferric carboxymaltose is associated with lowering of plasma phosphate levels in patients with gastric bypass surgery: a retrospective case series.
Pereira Portela C., Favre L., Locatelli I., Bonny O., 2024/07/24. Swiss medical weekly, 154 p. 3771. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A70D169292D]
Dabigatran accumulation in acute kidney injury: is more better than less to prevent bleeding? A case report.
Matbouli R., Pantet O., Castioni J., Vakilzadeh N., Alberio L., Hugli O., 2024/07/17. International journal of emergency medicine, 17 (1) p. 91. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_24E2BF781FD5]
Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve.
Burnier M., 2024/07. Expert review of pharmacoeconomics & outcomes research, 24 (6) pp. 749-758. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_21D3D421ADF5]
Thrombotic Microangiopathy as an Emerging Complication of Viral Vector-Based Gene Therapy.
Schwotzer N., El Sissy C., Desguerre I., Frémeaux-Bacchi V., Servais L., Fakhouri F., 2024/07. Kidney international reports, 9 (7) pp. 1995-2005. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B7BF2744AEC2]
Quantification of endogenous Angiotensin 1-10, 1-9, 1-8, 1-7, and 1-5 in human plasma using micro-UHPLC-MS/MS: Outlining the importance of the pre-analytics for reliable results.
Maurer J., de Groot A., Martin L., Grouzmann E., Wuerzner G., Eugster P.J., 2024/06/15. Journal of pharmaceutical and biomedical analysis, 243 p. 116101. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_581711601DE7]
Effects of empagliflozin on reproductive system in men without diabetes.
Kosinski C., Papadakis G.E., Salamin O., Kuuranne T., Nicoli R., Pitteloud N., Zanchi A., 2024/06/14. Scientific reports, 14 (1) p. 13802. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A7E8B905DAB3]
 
Rôle de la chirurgie dans l’hyperaldostéronisme primaire [Surgical treatment for primary aldosteronism]
Luzuy-Guarnero V., Mehier P., Wuerzner G., Matter M., Zingg T., 2024/06/12. Revue medicale suisse, 20 (878) pp. 1163-1166. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9633EB05D80F]
 
Tortuosity in non-atherosclerotic vascular diseases is associated with age, arterial aneurysms, and hypertension.
Luta X., Zanchi F., Fresa M., Porccedu E., Keller S., Bouchardy J., Déglise S., Qanadli S.D., Kirsch M., Wuerzner G. et al., 2024/06/07. Orphanet journal of rare diseases, 19 (1) p. 227. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_363885DD6CBD]
 
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern.
Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Kjeldsen S.E., Muiesan M.L., Thomopoulos C., Tsioufis K., Mancia G., 2024/06/01. Journal of hypertension, 42 (6) pp. 966-967. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6ECE95E78CE4]
 
Ten tips from the Swiss Working Group on Sustainable Nephrology on how to go green in your dialysis unit.
Pruijm M., Rho E., Woywodt A., Segerer S., 2024/06. Clinical kidney journal, 17 (6) pp. sfae144. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA0B7D394D5F]
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.
Sarafidis P., Schmieder R., Burnier M., Persu A., Januszewicz A., Halimi J.M., Arici M., Ortiz A., Wanner C., Mancia G. et al., 2024/05/31. Nephrology, dialysis, transplantation, 39 (6) pp. 929-943. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_375A45238359]
A new, deep learning-based method for the analysis of autopsy kidney samples used to study sex differences in glomerular density and size in a forensic population.
Vilmont V., Ngatchou N., Lioux G., Kalucki S., Brito W., Burnier M., Rotman S., Lardi C., Pruijm M., 2024/05. International journal of legal medicine, 138 (3) pp. 873-882. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6772A8E19616]
 
Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies.
Maisons V., Duval A., Mesnard L., Frimat M., Fakhouri F., Grangé S., Servais A., Cartery C., Fauchier L., Coppo P. et al., 2024/05. Kidney international, 105 (5) pp. 1100-1112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9A8D1EA78FBB]
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines.
Mancia G., Brunström M., Burnier M., Grassi G., Januszewicz A., Kjeldsen S.E., Muiesan M.L., Thomopoulos C., Tsioufis K., Kreutz R., 2024/05. Hypertension, 81 (5) pp. 1021-1030. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_839A036770BB]
Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial.
Mulatero P., Wuerzner G., Groessl M., Sconfienza E., Damianaki A., Forestiero V., Vogt B., Brunner H., Gerlock T., Steele R. et al., 2024/05. EClinicalMedicine, 71 p. 102576. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4E88C43094D3]
 
The Case | Acute kidney injury in a patient with systemic necrotizing lesions.
Kissling S., Rotman S., Fakhouri F., 2024/05. Kidney international, 105 (5) pp. 1133-1134. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CAA65B912D5]
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma.
Joo V., Abdelhamid K., Noto A., Latifyan S., Martina F., Daoudlarian D., De Micheli R., Pruijm M., Peters S., Hullin R. et al., 2024/04/30. Nature communications, 15 (1) p. 3664. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4D3A2A46F635]
Medical Measures in Hypertensives Considered Resistant.
Fadl Elmula FEM, Mariampillai J.E., Heimark S., Kjeldsen S.E., Burnier M., 2024/04/15. American journal of hypertension, 37 (5) pp. 307-317. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F534B9B1153]
Incidence of Common Glomerular Diseases Other Than Collapsing Glomerulopathy is Not Increased After SARS-CoV-2 Infection.
Diebold M., Enzler-Tschudy A., Helmchen B.M., Hopfer H., Kim M.J., Moll S., Nanchen G., Rotman S., Seeger H., Kistler A.D., 2024/04. Kidney international reports, 9 (4) pp. 1122-1126. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9704D2173BE4]
 
The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
Dhayat N.A., Mattmann C., Seeger H., Ritter A., Ernandez T., Stoermann-Chopard C., Buchkremer F., Segerer S., Roth B., Wuerzner G. et al., 2024/04. Kidney international reports, 9 (4) pp. 1072-1082. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19D4EA1D4C94]
 
Use of individual antihypertensive drug classes and combination therapies during the COVID-19 pandemic in Poland: a cross-sectional, nationwide study in the years 2019-2021.
Dobrowolski P., Prejbisz A., Bożek G., Koń B., Machnio A., Urbański F., Nowak F., Topór-Mądry R., Burnier M., Januszewicz A. et al., 2024/03/27. Polish archives of internal medicine, 134 (3) p. 16647. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9629B160A0AB]
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines.
Mancia G., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Kjeldsen S.E., Kreutz R., 2024/03. European journal of internal medicine, 121 pp. 4-8. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_12C8E07BCCBD]
 
Lithiase rénale, un changement de paradigme? [Change in the prevention of kidney stones]
Derouet C., Kissling S., Roth B., Bonny O., Schwotzer N., 2024/02/28. Revue medicale suisse, 20 (863) pp. 436-440. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6DEFEDFEA852]
 
Néphrologie de précision.
De Seigneux S., Fakhouri F., 2024/02/28. Revue medicale suisse, 20 (863) p. 419. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4C4F8CB98A0B]
 
Survenue d’une insuffisance rénale aiguë chez un patient sous traitement oncologique [Acute renal failure in a patient undergoing oncological treatment]
Mas L., Rosset-Zufferey S., 2024/02/28. Revue medicale suisse, 20 (863) pp. 425-429. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F5AFF5384C3F]
 
Diurétiques thiazidiques. Quelques considérations utiles en pratique clinique [Thiazid diuretics : some useful considerations in clinical practice]
Boucourt J., Petignat P.A., Wuerzner G., Gobin N., 2024/02/07. Revue medicale suisse, 20 (860) pp. 294-299. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F548E63AE48F]
The current best drug treatment for hypertensive heart failure with preserved ejection fraction.
Rist A., Sevre K., Wachtell K., Devereux R.B., Aurigemma G.P., Smiseth O.A., Kjeldsen S.E., Julius S., Pitt B., Burnier M. et al., 2024/02. European journal of internal medicine, 120 pp. 3-10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2444A51BE43E]
The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient.
Grütter S., Haefliger D., Wuerzner G., Yerly P., Bouchardy J., Rutz T., 2024/02. CJC pediatric and congenital heart disease, 3 (1) pp. 11-13. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8124EBF0DD1D]
Contrast-enhanced ultrasonography reveals a lower cortical perfusion and a decreased renal flow reserve in hypertensive patients.
Damianaki A., Hendriks-Balk M., Brito W., Polychronopoulou E., Theiler K., Maillard M., Maurer J., Eugster P., Pruijm M., Wuerzner G., 2024/01/31. Nephrology, dialysis, transplantation, 39 (2) pp. 242-250. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_FE31072D46DB]
 
Hypertension artérielle : ce qui a changé en 2023 [Hypertension: what's new in 2023]
Wuerzner G., Ponte B., Pechere-Bertschi A., 2024/01/31. Revue medicale suisse, 20 (859) pp. 252-254. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_881915641D7B]
Propofol sedation in routine endoscopy: A case series comparing target controlled infusion vs manually controlled bolus concept.
Sarraj R., Theiler L., Vakilzadeh N., Krupka N., Wiest R., 2024/01/16. World journal of gastrointestinal endoscopy, 16 (1) pp. 11-17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C1CC84EA03AD]
 
Aldosterone in the brain and cognition: knowns and unknowns.
Nieckarz A., Graff B., Burnier M., Marcinkowska A.B., Narkiewicz K., 2024. Frontiers in endocrinology, 15 p. 1456211. Peer-reviewed.
[DOI][Pmid][serval:BIB_B32435DA4CBD]
Association of serum copeptin and urinary uromodulin with kidney function, blood pressure and albuminuria at 6 weeks post-partum in pre-eclampsia.
Jaques D.A., Dufey Teso A., Wuerzner G., Martinez De Tejada B., Santagata M., Othenin Girard V., Le Tinier B., Pechere Bertschi A., Ponte B., 2024. Frontiers in cardiovascular medicine, 11 p. 1310300. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_33A27E5FEAF5]
 
Editorial: Non-immunological care of the kidney transplant recipients.
Halfon M., Bonny O., Teta D., 2024. Frontiers in nephrology, 4 p. 1440359. Peer-reviewed.
[DOI][Pmid][serval:BIB_F460313783FF]
 
Gut microbiota associations with chronic kidney disease: insights into nutritional and inflammatory parameters.
Lazarevic V., Teta D., Pruijm M., Stoermann C., Marangon N., Mareschal J., Solano R., Wurzner-Ghajarzadeh A., Gaïa N., Cani P.D. et al., 2024. Frontiers in microbiology, 15 p. 1298432. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_77102C9B7410]
Hypertension in a Patient With Polycystic Kidney Disease Complicated by Concomitant Pheochromocytoma.
Ameti A., Kopp P.A., Pitteloud N., Wuerzner G., Grouzmann E., Matter M., Lamine F., Phan O., 2024. AACE clinical case reports, 10 (4) pp. 136-139. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7B764FF92092]
Optimizing drug adherence in hypertension: More than a mind game.
Robberechts T., Stoenoiu M.S., Burnier M., Persu A., 2024. Kardiologia polska, 82 (3) pp. 259-266. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7CE472FF2113]
Pregnancy as a susceptible state for thrombotic microangiopathies.
Frimat M., Gnemmi V., Stichelbout M., Provôt F., Fakhouri F., 2024. Frontiers in medicine, 11 p. 1343060. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E4D4F681F85]
The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study.
Bandiera C., Dotta-Celio J., Locatelli I., Nobre D., Wuerzner G., Pruijm M., Lamine F., Burnier M., Zanchi A., Schneider M.P., 2024. Frontiers in pharmacology, 15 p. 1294436. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_066459A6BF3A]
The role of adherence in patients with chronic diseases.
Burnier M., 2024/01. European journal of internal medicine, 119 pp. 1-5. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_246034D5202B]
The urine-to-plasma urea concentration ratio is associated with eGFR and eGFR decline over time in a population cohort.
Petrovic D., Bankir L., Ponte B., Pruijm M., Corre T., Ghobril J.P., Bouatou Y., Ackermann D., Vogt B., Bochud M., 2024. Nephrology, dialysis, transplantation, 39 (1) pp. 122-132. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC6B42647AB8]
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence.
Sevre K., Rist A., Wachtell K., Devereux R.B., Aurigemma G.P., Smiseth O.A., Kjeldsen S.E., Julius S., Pitt B., Burnier M. et al., 2024/01/01. American journal of hypertension, 37 (1) pp. 1-14. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_962EADA3BC8E]
2023
 
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).
Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Agabiti-Rosei E., Algharably EAE et al., 2023/12/01. Journal of hypertension, 41 (12) pp. 1874-2071. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1685ABBB3425]
Atypical cystic hepatorenal disease in a 40-year-old female: What is the diagnosis? A nephrology zebra.
Barbey F., Maillard M., Cina V., Fakhouri F., 2023/12. Journal of nephrology, 36 (9) pp. 2651-2653. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EDE08B2F7EAB]
 
Performance of the Aktiia optical blood pressure measurement device in the elderly: a comparison with double blinded auscultation in different body positions.
Theiler K., Sola J., Damianaki A., Pfister A., Almeida T.P., Alexandre J., Vermare P., Wuerzner G., 2023/12. Blood pressure, 32 (1) p. 2281320. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_05F6671A3994]
TIME to face the reality about evening dosing of antihypertensive drugs in hypertension.
Kjeldsen S.E., Egan B.M., Narkiewicz K., Kreutz R., Burnier M., Oparil S., Mancia G., 2023/12. Blood pressure, 32 (1) pp. 1-3. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F0342E2ED706]
 
Women's health, cardiovascular risk and hypertension: the perspective still needs to improve.
Burnier M., Brguljan J., Algharably EAE, Kjeldsen S.E., Narkiewicz K., Egan B., Oparil S., Kreutz R., 2023/12. Blood pressure, 32 (1) p. 2193648. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E391CF7B9F3]
Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice.
Wang Q., Schäfer S.C., Haefliger J.A., Maillard M.P., Alonso F., 2023/11/28. International journal of molecular sciences, 24 (23) p. 16858. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_282ADF82D5F9]
A Policy Call to Address Rare Kidney Disease in Health Care Plans.
Vanholder R., Coppo R., Bos WJW, Damato E., Fakhouri F., Humphreys A., Nistor I., Ortiz A., Pistollato M., Scheres E. et al., 2023/11/01. Clinical journal of the American Society of Nephrology, 18 (11) pp. 1510-1518. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8E9E3AF30D72]
 
Diagnosis of cardiovascular disease in patients with chronic kidney disease.
Zoccali C., Mark P.B., Sarafidis P., Agarwal R., Adamczak M., Bueno de Oliveira R., Massy Z.A., Kotanko P., Ferro C.J., Wanner C. et al., 2023/11. Nature reviews. Nephrology, 19 (11) pp. 733-746. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_876F8357F955]
 
Estimation de la fonction rénale chez la personne âgée : quelle formule utiliser ? [Estimating renal function in older patients : which is the best formula?]
Cilla F., Sabione I., Pruijm M., Humbert M., D'Amelio P., 2023/11/01. Revue medicale suisse, 19 (848) pp. 2066-2071. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_450EDF75AD07]
 
Renal tubular SGK1 is required to achieve blood pressure surge and circadian rhythm.
Staub O., Debonneville A., Stifanelli M., Juffre A., Maillard M.P., Gumz M.L., Al-Qusairi L., 2023/11/01. American journal of physiology. Renal physiology, 325 (5) pp. F629-F637. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_12827BBF62FA]
 
Targeting the Complement Pathway in Kidney Transplantation.
Golshayan D., Schwotzer N., Fakhouri F., Zuber J., 2023/11/01. Journal of the American Society of Nephrology, 34 (11) pp. 1776-1792. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6F71F0C87493]
 
Clinical significance of small nerve fiber involvement in the early diagnosis and treatment of patients with Fabry disease.
Kokotis P., Zompola C., Anastasakis A., Damianaki A., Bountziouka C., Mpora M., Papatheodorou S., Tsivgoulis G., 2023/10/15. Journal of the neurological sciences, 453 p. 120776. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C70D8B7983F9]
Blood pressure control in tertiary-care hypertensive patients during COVID-19 pandemic
Wolf Jacek, Nieckarz Anna, Panfil Anna, Białas Aleksandra, Sternicka Julia, Jędrzejewski Łukasz, Hoffmann Michał, Szyndler Anna, Prejbisz Aleksander, Burnier Michel et al., 2023/09/30. Arterial Hypertension, 27 (3) pp. 145-151.
[URN][DOI][WoS][serval:BIB_A8801E65C251]
 
Treatment and long-term outcome in primary nephrogenic diabetes insipidus
Lopez-Garcia Sergio C, Downie Mallory L, Kim Ji Soo, Boyer Olivia, Walsh Stephen B, Nijenhuis Tom, Papizh Svetlana, Yadav Pallavi, Reynolds Ben C, Decramer Stéphane et al., 2023/09/29. Nephrology Dialysis Transplantation, 38 (10) pp. 2120-2130. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BD4F8353A96D]
Kidney-Specific Membrane-Bound Serine Proteases CAP1/Prss8 and CAP3/St14 Affect ENaC Subunit Abundances but Not Its Activity.
Ehret E., Stroh S., Auberson M., Ino F., Jäger Y., Maillard M., Szabo R., Bugge T.H., Frateschi S., Hummler E., 2023/09/23. Cells, 12 (19). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31898AC30642]
Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology.
Von Tokarski F., Fillon A., Maisons V., Thoreau B., Bayer G., Gatault P., Longuet H., Sautenet B., Buchler M., Vigneau C. et al., 2023/09/20. BMC nephrology, 24 (1) p. 278. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_78DE94C96F85]
 
Hyperkaliémie chez le patient hypertendu : plus qu’une coïncidence ? [Hyperkaliemia in hypertensive patients : more than a coincidence?]
Damianaki A., Wuerzner G., 2023/09/13. Revue medicale suisse, 19 (841) pp. 1647-1650. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7E99572678E4]
 
Prise en charge de l’hypertension artérielle chez les athlètes [Management of hypertension in athletes]
Leanizbarrutia G., Wuerzner G., 2023/09/13. Revue medicale suisse, 19 (841) pp. 1662-1667. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CE8C736A6C90]
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
Zoccali C., Mallamaci F., Adamczak M., de Oliveira R.B., Massy Z.A., Sarafidis P., Agarwal R., Mark P.B., Kotanko P., Ferro C.J. et al., 2023/09/05. Cardiovascular research, 119 (11) pp. 2017-2032. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FDDBFAFA00AA]
How to optimize the use of diuretics in patients with heart failure?
Burnier M., Narkiewicz K., Kjeldsen S.E., 2023/09. Kardiologia polska, 81 (10) pp. 944-949. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5FE1A04EE675]
 
Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension.
Mancia G., Cappuccio F.P., Burnier M., Coca A., Persu A., Borghi C., Kreutz R., Sanner B., 2023/09. Journal of internal medicine, 294 (3) pp. 251-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D6C0EDD666B]
Renal FGF23 signaling depends on redox protein Memo1 and promotes orthovanadate-sensitive protein phosphotyrosyl phosphatase activity.
Bartos K., Ramakrishnan S.K., Braga-Lagache S., Hänzi B., Durussel F., Prakash Sridharan A., Zhu Y., Sheehan D., Hynes N.E., Bonny O. et al., 2023/09. Journal of cell communication and signaling, 17 (3) pp. 705-722. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_042660164690]
 
CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.
Mulatero P., Groessl M., Vogt B., Schumacher C., Steele R.E., Brooks A., Hossack S., Brunner H.R., 2023/08. British journal of clinical pharmacology, 89 (8) pp. 2483-2496. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_220526306148]
 
Traduction et validation en langue française de l’instrument « Diabetes Knowledge Questionnaire » [Translation of the Diabetes Knowledge Questionnaire into French and its validation]
Helou N., Rapin M., Nobre D., Zanchi A., 2023/07/12. Recherche en soins infirmiers, 152 (1) pp. 60-76. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3C07763A4BA]
Design and Rationale of the APPELHUS Phase 3 Open-Label Study of Factor B Inhibitor Iptacopan for Atypical Hemolytic Uremic Syndrome.
Kavanagh D., Greenbaum L.A., Bagga A., Karki R.G., Chen C.W., Vasudevan S., Charney A., Dahlke M., Fakhouri F., 2023/07. Kidney international reports, 8 (7) pp. 1332-1341. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1375C4F64064]
Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.
Legay C., Haeusermann T., Pasquier J., Chatelan A., Fuster D.G., Dhayat N., Seeger H., Ritter A., Mohebbi N., Ernandez T. et al., 2023/07. Journal of renal nutrition, 33 (4) pp. 555-565. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C2EAF4FBE5F1]
 
Partnership between patients and interprofessional healthcare providers along the multifaceted journey to medication adherence.
Schneider M.P., Burnier M., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 1992-1995. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_310D79A2F509]
 
Prise en charge des maladies rénales génétiques : expérience locale et importance du réseau [Management of genetic renal disorders: local experience and importance of the network]
Bonny O., Ketterer A., Hermida S., Superti-Furga A., Venetz J.P., Chehade H., Fodstad H., Cina V., Parvex P., Paoloni-Giacobino A. et al., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1245-1249. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9C5896980D20]
Determinants of Renal Micro-Perfusion as Assessed with Contrast-Enhanced Ultrasound in Healthy Males and Females.
Ulpiano Trillig A., Damianaki A., Hendriks-Balk M., Brito W., Garessus J., Burnier M., Wuerzner G., Pruijm M., 2023/06/20. Journal of clinical medicine, 12 (12) p. 4141. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_36659E8E9115]
Sodium/Glucose Cotransporter 2 Inhibition and Urolithiasis: The Effect of Urinary pH and Citrate.
Harmacek D., Bonny O., 2023/06. Kidney international reports, 8 (6) p. 1268. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B99134AAED85]
 
Néphropathie diabétique : soutenir l’adhésion médicamenteuse de façon interprofessionnelle [Diabetic nephropathy: Interprofessional support of medication adherence]
Bandiera C., Duarte D., Dotta-Celio J., Zanchi A., Schneider M.P., 2023/05/31. Revue medicale suisse, 19 (829) pp. 1085-1089. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4D4B823B11B7]
 
Hemolytic Uremic Syndrome: A Question of Terminology.
Schwotzer N., Frémeaux-Bacchi V., Fakhouri F., 2023/05/29. Clinical journal of the American Society of Nephrology, 18 (7) pp. 831-833. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96ABFE99CAA2]
 
A Rare Case of Nephrotic Syndrome in the Setting of Sjogren Syndrome-related Cryoglobulinemic Vasculitis.
Alexakou Z., Damianaki K., Stambolliu E., Kourniotis D., Mpora M., Petras D., 2023/05/01. Saudi journal of kidney diseases and transplantation, 34 (3) pp. 265-269. Peer-reviewed.
[DOI][Pmid][serval:BIB_D1F04B852457]
Expanding the potential therapeutic options of hemoperfusion in the era of improved sorbent biocompatibility.
Damianaki A., Stambolliu E., Alexakou Z., Petras D., 2023/05. Kidney research and clinical practice, 42 (3) pp. 298-311. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0C698F05D5BB]
 
Variability of 24-Hour Sodium Urinary Excretion in Young Healthy Males Based on Consecutive Urine Collections: Impact on Categorization of Salt Intake.
Jaques D.A., Ponte B., Olivier V., de Seigneux S., Feraille E., Burnier M., Pechère-Bertschi A., 2023/05. Journal of renal nutrition, 33 (3) pp. 450-455. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_39314F6C786C]
 
Key questions regarding the SYMPLICITY HTN-3 trial.
Kjeldsen S.E., Burnier M., Narkiewicz K., Kreutz R., Mancia G., 2023/04/22. Lancet, 401 (10385) pp. 1336-1337. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E3B116250262]
 
Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease.
Burnier M., Damianaki A., 2023/04/14. Circulation research, 132 (8) pp. 1050-1063. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F745C0868C6]
Granulomatose avec polyangéite : quoi de neuf ? [Granulomatosis with polyangiitis: what's new?]
Ringwald M., Chevalley D., Bongard C., Kissling S., Rotman S., Von Garnier C., Ribi C., Comte D., 2023/04/05. Revue medicale suisse, 19 (821) pp. 674-679. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D369BEFFD011]
Maladie des anticorps anti-membrane basale glomérulaire [Anti-glomerular basement membrane disease]
Stevanin M., Kissling S., Daccord C., Rotman S., Comte D., Ribi C., 2023/04/05. Revue medicale suisse, 19 (821) pp. 680-685. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_89863117120D]
The phytase RipBL1 enables the assignment of a specific inositol phosphate isomer as a structural component of human kidney stones.
Liu G., Riemer E., Schneider R., Cabuzu D., Bonny O., Wagner C.A., Qiu D., Saiardi A., Strauss A., Lahaye T. et al., 2023/04/05. RSC chemical biology, 4 (4) pp. 300-309. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4A25E5BC13DE]
 
How I diagnose and treat atypical hemolytic uremic syndrome.
Fakhouri F., Schwotzer N., Frémeaux-Bacchi V., 2023/03/02. Blood, 141 (9) pp. 984-995. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_05099DE4C4DC]
 
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat N.A., Bonny O., Roth B., Christe A., Ritter A., Mohebbi N., Faller N., Pellegrini L., Bedino G., Venzin R.M. et al., 2023/03/02. The New England journal of medicine, 388 (9) pp. 781-791. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58067765B755]
Consommation de drogues par voie itraveineuse et maladies rénales [Intravenous drug use and kidney disease]
Rosset-Zufferey S., Daeppen J.B., Pruijm M., 2023/03/01. Revue medicale suisse, 19 (816) pp. 411-416. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D7282904BCED]
Grossesse et insuffisance rénale chronique : quelle prise en charge en 2023 ? [Pregnancy and chronic renal failure: what is new in 2023?]
Vakilzadeh N., Legardeur H., Desseauve D., Phan O., 2023/03/01. Revue medicale suisse, 19 (816) pp. 401-405. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_14DB22FD05C1]
La néphrologie : une spécialité de maladies rares.
Fakhouri F., De Seigneux S., 2023/03/01. Revue medicale suisse, 19 (816) p. 395. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AA0ACD6946E6]
Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations.
Burnier M., Redon J., Volpe M., 2023/03. High blood pressure & cardiovascular prevention, 30 (2) pp. 109-121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E88B8BE11962]
 
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management.
Fakhouri F., Schwotzer N., Cabiddu G., Barratt J., Legardeur H., Garovic V., Orozco-Guillen A., Wetzels J., Daugas E., Moroni G. et al., 2023/02. Kidney international, 103 (2) pp. 264-281. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC0ACA8AF622]
Hypertension artérielle : ce qui a changé en 2022 [Hypertension: what's new in 2022]
Wuerzner G., Ponte B., Pechère-Bertschi A., 2023/02/01. Revue medicale suisse, 19 (812) pp. 221-224. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E20EDE7E809D]
 
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
Ortiz A., Ferro C.J., Balafa O., Burnier M., Ekart R., Halimi J.M., Kreutz R., Mark P.B., Persu A., Rossignol P. et al., 2023/01/23. Nephrology, dialysis, transplantation, 38 (1) pp. 10-25. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_536AFB717F2D]
Dietary salt and NCDs: Burden, epidemiology and priority interventions
Bovet Pascal, Burnier Michel, Banatvala Nick, Nederveen Leo, 2023/01/18. pp. 157-163 dans Banatvala Nick, Bovet Pascal (eds.) Noncommunicable Diseases: A Compendium chap. 21, Routledge.
[URN][DOI][serval:BIB_BCE49226BC36]
Hypertension: Burden, epidemiology and priority interventions
Bovet Pascal, Schutte Alta E., Banatvala Nick, Burnier Michel, 2023/01/18. pp. 58-65 dans Banatvala Nick, Bovet Pascal (eds.) Noncommunicable Diseases: A Compendium chap. 8, Routledge.
[URN][DOI][serval:BIB_AE3A67A24D23]
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology.
Zanchi A., Jehle A.W., Lamine F., Vogt B., Czerlau C., Bilz S., Seeger H., de Seigneux S., 2023/01/06. Swiss medical weekly, 153 p. 40004. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_761A8C74E5BC]
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease.
Trucello L., Nobre D., Sabaratnam V., Bonny O., Wuerzner G., Burnier M., Fakhouri F., Pruijm M., Zanchi A., 2023. Frontiers in cardiovascular medicine, 10 p. 1230227. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_199BBB7CA1E4]
Gout and hyperuricaemia: modifiable cardiovascular risk factors?
Burnier M., 2023. Frontiers in cardiovascular medicine, 10 p. 1190069. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C350B8F456E2]
 
Life-course socioeconomic factors are associated with markers of epigenetic aging in a population-based study.
Petrovic D., Carmeli C., Sandoval J.L., Bodinier B., Chadeau-Hyam M., Schrempft S., Ehret G., Dhayat N.A., Ponte B., Pruijm M. et al., 2023/01. Psychoneuroendocrinology, 147 p. 105976. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6CAF885BD72]
Renal Denervation: A Practical Guide for Health Professionals Managing Hypertension.
Schmieder R., Burnier M., East C., Tsioufis K., Delaney S., 2023. Interventional cardiology, 18 pp. e06. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E77A502C0302]
The impact of war on the development and progression of arterial hypertension and cardiovascular disease: protocol of a prospective study among Ukrainian female refugees.
Shalimova A., Stoenoiu M.S., Cubała W.J., Burnier M., Persu A., Narkiewicz K., 2023. Frontiers in cardiovascular medicine, 10 p. 1324367. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE274E13CA4E]
The Swiss Kidney Stone Cohort: A Longitudinal, Multicentric, Observational Cohort to Study Course and Causes of Kidney Stone Disease in Switzerland.
Bonny O., Fuster D., Seeger H., Ernandez T., Buchkremer F., Wuerzner G., Dhayat N., Ritter A., Stoermann C., Segerer S. et al., 2023. Kidney & blood pressure research, 48 (1) pp. 194-201. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3B86FBAF801E]
2022
PhenoExplorer: An Interactive Web-based Platform for Exploring (Epi)Genome-Wide Associations Using a Swiss Population-based Study.
Ghobril J.P., Petrovic D., Ehret G., Ponte B., Pruijm M., Ackermann D., Vogt B., Stringhini S., Thomas A., Chamberlain J. et al., 2022/12/21. Chimia, 76 (12) pp. 1052-1062. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_390F89691CE1]
A 30th anniversary and a glimpse of the future.
Burnier M., Kjeldsen S.E., 2022/12. Blood pressure, 31 (1) pp. 1-3. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_153462F73BCA]
Accuracy of blood pressure measurement across BMI categories using the OptiBP™ mobile application.
Caillat M., Degott J., Wuerzner A., Proençain M., Bonnier G., Knebel J.F., Stoll C., Christen U., Durgnat V., Hofmann G. et al., 2022/12. Blood pressure, 31 (1) pp. 288-296. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44BA3AFA4503]
High blood pressure screening in pharmacies during May Measurement Month campaigns in Switzerland.
Damianaki A., Theiler K., Beaney T., Wang W., Burnier M., Wuerzner G., 2022/12. Blood pressure, 31 (1) pp. 129-138. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_46C1E149F738]
Hypertension management during the COVID-19 pandemic: what can we learn for the future?
Burnier M., Kjeldsen S.E., Narkiewicz K., Egan B., Kreutz R., 2022/12. Blood pressure, 31 (1) pp. 47-49. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EF3DAF2FB021]
Hypoxia briefly increases diuresis but reduces plasma volume by fluid redistribution in women.
Roche J., Rasmussen P., Gatterer H., Roveri G., Turner R., van Hall G., Maillard M., Walzl A., Kob M., Strapazzon G. et al., 2022/12/01. American journal of physiology. Heart and circulatory physiology, 323 (6) pp. H1068-H1079. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F2461EC1A85F]
Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
Diebold M., Locher E., Boide P., Enzler-Tschudy A., Faivre A., Fischer I., Helmchen B., Hopfer H., Kim M.J., Moll S. et al., 2022/12. Kidney international, 102 (6) pp. 1409-1419. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_344CA7F5AFE5]
Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure.
Narkiewicz K., Kjeldsen S.E., Egan B.M., Kreutz R., Burnier M., 2022/12. Blood pressure, 31 (1) pp. 207-209. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4E3DE4C7D03F]
Saxagliptin: A potential doping agent? A randomized, double-blinded, placebo-controlled, and crossover pilot study in young active men.
Bourdillon N., Eugster P.J., Vocat C., Nguyen T., Wuerzner G., Grouzmann E., Millet G.P., 2022/12. Physiological reports, 10 (23) pp. e15515. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_23C966666087]
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.
Egan B.M., Kjeldsen S.E., Narkiewicz K., Kreutz R., Burnier M., 2022/12. Blood pressure, 31 (1) pp. 164-168. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A23838C471A5]
 
Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy.
Kjeldsen S.E., Egan B.M., Narkiewicz K., Kreutz R., Burnier M., Oparil S., 2022/12. Blood pressure, 31 (1) pp. 125-128. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A315F72BE81]
 
Hyperpolarized (1-13C)Alaninamide Is a Multifunctional In Vivo Sensor of Aminopeptidase N Activity, pH, and CO2.
Radaelli A., Ortiz D., Michelotti A., Roche M., Hata R., Sando S., Bonny O., Gruetter R., Yoshihara HAI, 2022/10/28. ACS sensors, 7 (10) pp. 2987-2994. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1838EF0C3263]
Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
Messerli F.H., Bavishi C., Brguljan J., Burnier M., Dobner S., Elijovich F., Ferdinand K.C., Kjeldsen S., Laffer C.L., S Ram C.V. et al., 2022/10/01. Journal of hypertension, 40 (10) pp. 1859-1875. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B326C47342F5]
Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study.
Bandiera C., Lam L., Locatelli I., Dotta-Celio J., Duarte D., Wuerzner G., Pruijm M., Zanchi A., Schneider M.P., 2022/09/27. Diabetology & metabolic syndrome, 14 (1) p. 140. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_679FC960BEF9]
 
Defining intradialytic hypertension: the importance of measuring blood pressure accurately.
Wuerzner G., Pruijm M., Burnier M., 2022/09/22. Nephrology, dialysis, transplantation, 37 (10) pp. 1783-1785. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5065B491E932]
En quoi la prise en charge de l’hypertendu diabétique est-elle différente? [How is the management of diabetic hypertensive patients different?]
Dufey Teso A., Lamine F., Zanchi A., Wuerzner G., 2022/09/14. Revue medicale suisse, 18 (795) pp. 1710-1716. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B533CB301DE1]
Mesures de la pression artérielle dans des situations particulières [Measurement of arterial blood pressure in special situations]
Theiler K., Kirsch M., Wuerzner G., 2022/09/14. Revue medicale suisse, 18 (795) pp. 1698-1701. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_15F1DB3EF2F5]
Pression sur les médecins en formation
Ponte B., Wuerzner G., Pechère-Bertschi A., 2022/09/14. Revue medicale suisse, 18 (795) p. 1687. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_36E546026C95]
Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
Hirzel C., Projer L., Atkinson A., Surial B., Mueller N.J., Manuel O., Mombelli M., van Delden C., Hirsch H.H., Boggian K. et al., 2022/09/01. Transplantation, 106 (9) pp. 1875-1883. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_377ED42F9047]
May Measurement Month 2017-2019: results from Switzerland<sup></sup>.
Damianaki A., Wang W., Beaney T., Burkard T., Sudano I., Burnier M., Wuerzner G., 2022/09. European heart journal supplements, 24 (Suppl F) pp. F38-F40. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30A37F3EB95A]
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
Eugster P.J., Maurer J., Vocat C., Abid K., Matter M., Wuerzner G., Trepp R., Fischli S., Henzen C., Kolb W. et al., 2022/09/01. Clinica chimica acta; international journal of clinical chemistry, 534 pp. 146-155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_569E60EE2BE0]
 
Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
Stergiou G.S., Mukkamala R., Avolio A., Kyriakoulis K.G., Mieke S., Murray A., Parati G., Schutte A.E., Sharman J.E., Asmar R. et al., 2022/08/01. Journal of hypertension, 40 (8) pp. 1449-1460. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_63F4F91CA525]
 
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.
Lomax-Browne H.J., Medjeral-Thomas N.R., Barbour S.J., Gisby J., Han H., Bomback A.S., Fervenza F.C., Cairns T.H., Szydlo R., Tan S.J. et al., 2022/07. Clinical journal of the American Society of Nephrology, 17 (7) pp. 994-1007. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C363C4B1A535]
 
Hypomagnesemia, Hypocalcemia, and Tubulointerstitial Nephropathy Caused by Claudin-16 Autoantibodies.
Figueres L., Bruneau S., Prot-Bertoye C., Brideau G., Néel M., Griveau C., Cheval L., Bignon Y., Dimitrov J., Dejoie T. et al., 2022/07. Journal of the American Society of Nephrology, 33 (7) pp. 1402-1410. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2277A9AE7D7D]
Kidney-Specific CAP1/Prss8-Deficient Mice Maintain ENaC-Mediated Sodium Balance through an Aldosterone Independent Pathway.
Ehret E., Jäger Y., Sergi C., Mérillat A.M., Peyrollaz T., Anand D., Wang Q., Ino F., Maillard M., Kellenberger S. et al., 2022/06/16. International journal of molecular sciences, 23 (12) p. 6745. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CEC8322435F6]
 
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.
Harmacek D., Pruijm M., Burnier M., Muller M.E., Ghajarzadeh-Wurzner A., Bonny O., Zanchi A., 2022/06. Journal of the American Society of Nephrology, 33 (6) pp. 1073-1075. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B566D465A0A5]
The Rational Use of Complement Inhibitors in Kidney Diseases.
Fakhouri F., Schwotzer N., Golshayan D., Frémeaux-Bacchi V., 2022/06. Kidney international reports, 7 (6) pp. 1165-1178. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6B98D384D8F5]
Improving the Management of Hypertension by Tackling Awareness, Adherence, and Clinical Inertia: A Symposium Report.
Pathak A., Poulter N.R., Kavanagh M., Kreutz R., Burnier M., 2022/05. American journal of cardiovascular drugs, 22 (3) pp. 251-261. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_897B7757F21C]
 
Metformin versus SGLT-2 inhibitors: how low can we go?
Pruijm M., Phan O., Zanchi A., 2022/05. Kidney international, 101 (5) pp. 874-877. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_465B201E6BF2]
 
Implanted System for Orthostatic Hypotension in Multiple-System Atrophy.
Squair J.W., Berney M., Castro Jimenez M., Hankov N., Demesmaeker R., Amir S., Paley A., Hernandez-Charpak S., Dumont G., Asboth L. et al., 2022/04/07. The New England journal of medicine, 386 (14) pp. 1339-1344. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CDFEFD334F15]
 
Association between post-traumatic stress disorder and hypertension in Congolese exposed to violence: a case-control study.
Bapolisi A., Maurage P., Pappaccogli M., Georges CMG, Petit G., Balola M., Cikomola C., Bisimwa G., Burnier M., Persu A. et al., 2022/04/01. Journal of hypertension, 40 (4) pp. 685-691. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFF7B80A02EF]
Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises.
Eugster P.J., Bourdillon N., Vocat C., Wuerzner G., Nguyen T., Millet G.P., Grouzmann E., 2022/04. Neuropeptides, 92 p. 102232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0096429CF785]
Letter Regarding "Granulomatous Inflammation and Hypercalcemia in Patients With Severe Systemic Oxalosis".
Halfon M., Schwotzer N., Pruijm M., Bonny O., 2022/04. Kidney international reports, 7 (4) pp. 930-931. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C22BC7B62C1E]
Methods for the dietary assessment of adult kidney stone formers: a scoping review.
Legay C., Krasniqi T., Bourdet A., Bonny O., Bochud M., 2022/04. Journal of nephrology, 35 (3) pp. 821-830. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5C7ADDEABEA]
 
Relevance of deceased donor proteinuria for kidney transplantation: A comprehensive national cohort study.
Kuhn C., Born A., Karolin A., Lang B., Binet I., Golshayan D., Haidar F., Müller T.F., Schaub S., Immer F. et al., 2022/04. Clinical transplantation, 36 (4) pp. e14574. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F7453C7D9759]
 
Cortical perfusion as assessed with contrast-enhanced ultrasound is lower in patients with chronic kidney disease than in healthy subjects but increases under low salt conditions.
Garessus J., Brito W., Loncle N., Vanelli A., Hendriks-Balk M., Wuerzner G., Schneider A., Burnier M., Pruijm M., 2022/03/25. Nephrology, dialysis, transplantation, 37 (4) pp. 705-712. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AF32F83585F7]
 
Concomitant Urinary Triple Phosphate and Cystine Crystals.
Kissling S., Bonny O., 2022/03/24. The New England journal of medicine, 386 (12) p. 1165. Peer-reviewed.
[DOI][Pmid][serval:BIB_DACF6FC64BED]
 
Selling, buying and eating – a synthesis study on dietary patterns across language regions in Switzerland
Matthes Katarina L., Zuberbuehler Christine A., Rohrmann Sabine, Hartmann Christina, Siegrist Michael, Burnier Michel, Bochud Murielle, Zwahlen Marcel, Bender Nicole, Staub Kaspar, 2022/03/21. British Food Journal, 124 (5) pp. 1502-1518.
[DOI][WoS][serval:BIB_CCE3D3671925]
Hyperuricémie et maladie rénale : prise en charge [Management of hyperuricemia in chronic kidney disease]
Schwotzer N., Auberson M., Livio F., So A., Bonny O., 2022/03/02. Revue medicale suisse, 18 (771) pp. 379-384. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2FCE48D8B05C]
Nouveautés dans la pathophysiologie et le traitement de l’anémie rénale [New insights in the pathophysiology and treatment of renal anemia]
Vultaggio P., Loria F., Fakhouri F., Leuenberger N., Pruijm M., 2022/03/02. Revue medicale suisse, 18 (771) pp. 358-363. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C48E5B4F4AB8]
Syndrome néphrotique de l’adulte et autres protéinuries de fort debit [Nephrotic syndrome and other high-level proteinuria]
Ngatchou N., Kissling S., 2022/03/02. Revue medicale suisse, 18 (771) pp. 370-378. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CEDCB16973CA]
Vingt ans de néphrologie à Genève []
Martin P.Y., De Seigneux S., Fakhouri F., 2022/03/02. Revue medicale suisse, 18 (771) pp. 355-356. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8FAC22D06D91]
 
Monitoring of hemoglobin and erythropoiesis-related mRNA with dried blood spots in athletes and patients.
Loria F., Stutz A.P., Rocca A., Grabherr S., Kuuranne T., Pruijm M., Leuenberger N., 2022/03. Bioanalysis, 14 (5) pp. 241-251. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D12A0F09E1E]
New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy.
Damianaki A., Polychronopoulou E., Wuerzner G., Burnier M., 2022/03. High blood pressure & cardiovascular prevention, 29 (2) pp. 125-135. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EFFF2E71408F]
Dietary sodium intake does not alter renal potassium handling and blood pressure in healthy young males.
Pechère-Bertschi A., Olivier V., Burnier M., Udwan K., de Seigneux S., Ponte B., Maillard M., Martin P.Y., Feraille E., 2022/02/25. Nephrology, dialysis, transplantation, 37 (3) pp. 548-557. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_81177BECC2D0]
 
Clinical benefits of hypertension management: a look to the past to strengthen the future.
Burnier M., 2022/02/19. European journal of preventive cardiology, 29 (1) pp. 167-168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0B8CB62AC3C0]
Hypertension artérielle [Hypertension: novelties 2021]
Wuerzner G., Ponte B., Pechère-Bertschi A., 2022/02/02. Revue medicale suisse, 18 (767) pp. 169-172. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1F682BA43C88]
Changes of lipoprotein(a) levels with endogenous steroid hormones.
Tessitore E., Dobretz K., Dhayat N.A., Kern I., Ponte B., Pruijm M., Ackermann D., Estoppey S., Burnier M., Martin P.Y. et al., 2022/02. European journal of clinical investigation, 52 (2) pp. e13699. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5156A7619A31]
Acute decrease of urine calcium by amiloride in healthy volunteers under high-sodium diet.
Harmacek D., Blanchard A., Wuerzner G., Maillard M., Jeunemaitre X., Azizi M., Bonny O., 2022/01/25. Nephrology, dialysis, transplantation, 37 (2) pp. 298-303. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C900C42C9E5E]
 
Renal denervation for patients with chronic kidney disease and resistant hypertension: effective and safe but still not the panacea.
Burnier M., 2022/01/25. Nephrology, dialysis, transplantation, 37 (2) pp. 208-210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_86068DB3776E]
 
What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.
Halimi J.M., Thoreau B., von Tokarski F., Bauvois A., Gueguen J., Goin N., Barbet C., Cloarec S., Mérieau E., Lachot S. et al., 2022/01/20. BMC nephrology, 23 (1) p. 39. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D876EC19E052]
Prevalence and Factors Associated with Opioid Prescription in Swiss Chronic Hemodialysis Patients
Hennebel Clémence, Vilmont Valérie, Cherpillod Anne, Fumeaux David, Fakhouri Fadi, Livio Françoise, Burnier Michel, Pruijm Menno, 2022/01/02. Kidney and Dialysis, 2 (1) pp. 6-15.
[URN][DOI][serval:BIB_01CCFE785454]
A quantitative synthesis study on body mass index and associated factors among adult men and women in Switzerland.
Matthes K.L., Hartmann C., Siegrist M., Burnier M., Bochud M., Zwahlen M., Bender N., Staub K., 2022. Journal of nutritional science, 11 pp. e65. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9EDF1F8EB24E]
Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling.
Christou F., Pivin E., Denys A., Abid K.A., Zingg T., Matter M., Pechère-Bertschi A., Maillard M., Grouzmann E., Wuerzner G., 2022. Frontiers in endocrinology, 13 p. 842968. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF212A67D096]
 
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification
Ronsin C., Georges M., Chapelet-Debout A., Augusto J. F., Audard V., Lebourg L., Rubin S., Quemeneur T., Bataille P., Karras A. et al., 2022/01. Am J Kidney Dis, 79 (1) pp. 56-68 e1.
[DOI][Pmid][serval:BIB_6B6C00AAE259]
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis.
Pisano A., Mallamaci F., D'Arrigo G., Bolignano D., Wuerzner G., Ortiz A., Burnier M., Kanaan N., Sarafidis P., Persu A. et al., 2022/01. Clinical kidney journal, 15 (1) pp. 31-42. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AD3E1794750]
Contrast-Enhanced Ultrasonography Enables the Detection of a Cold Pressor Test-Induced Increase in Renal Microcirculation in Healthy Participants.
Hendriks-Balk M.C., Damianaki A., Polychronopoulou E., Brito W., Pruijm M., Wuerzner G., 2022. Frontiers in cardiovascular medicine, 9 p. 899327. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C556F68ED9A]
Contrast-Enhanced Ultrasound and Protein Shakes Are No Alternatives for Inulin Clearance and Meat to Assess Renal Functional Reserve in Humans.
Damianaki A., Brito W., Garessus J., Schneider A., Maillard M., Burnier M., Pruijm M., 2022. Kidney & blood pressure research, 47 (11) pp. 664-673. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7822A73648DA]
COVID-19 Pandemic in Dialysis Patients: The Swiss Experience.
Guidotti R., Pruijm M., Ambühl P.M., 2022. Frontiers in public health, 10 p. 795701. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DFF6DBAC9E0]
COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis.
Tylicki L., Biedunkiewicz B., Puchalska-Reglińska E., Gellert R., Burnier M., Wolf J., Dȩbska-Ślizień A., 2022. Frontiers in medicine, 9 p. 937167. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FB291B8802A]
Editorial: Insights in hypertension: 2021.
Burnier M., 2022. Frontiers in cardiovascular medicine, 9 p. 1003939. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9F8FF34C63EC]
Guidance for the Interpretation of Continual Cuffless Blood Pressure Data for the Diagnosis and Management of Hypertension.
Sola J., Cortes M., Perruchoud D., De Marco B., Lobo M.D., Pellaton C., Wuerzner G., Fisher NDL, Shah J., 2022. Frontiers in medical technology, 4 p. 899143. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EEC0708576BA]
Increased glucocorticoid metabolism in diabetic kidney disease.
Ackermann D., Vogt B., Bochud M., Burnier M., Martin P.Y., Paccaud F., Ehret G., Guessous I., Ponte B., Pruijm M. et al., 2022. PloS one, 17 (6) pp. e0269920. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_435625327C21]
Loss of Ecrg4 improves calcium oxalate nephropathy.
Cabuzu D., Ramakrishnan S.K., Moor M.B., Harmacek D., Auberson M., Durussel F., Bonny O., 2022. PloS one, 17 (10) pp. e0275972. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_41F133526EEF]
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
Bandiera C., Pasquier J., Locatelli I., Niquille A., Wuerzner G., Dotta-Celio J., Hachfeld A., Wandeler G., Wagner A.D., Csajka C. et al., 2022. Patient preference and adherence, 16 pp. 2313-2320. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_813F43A545D0]
Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing.
Lane D., Lawson A., Burns A., Azizi M., Burnier M., Jones DJL, Kably B., Khunti K., Kreutz R., Patel P. et al., 2022/01. Hypertension, 79 (1) pp. 12-23. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4D707A5E9093]
 
Pregnancy in Women with Atypical Hemolytic Uremic Syndrome
Rondeau E., Ardissino G., Caby-Tosi M. P., Al-Dakkak I., Fakhouri F., Miller B., Scully M., H. U. S. Registry HUS, 2022. Nephron, 146 (1) pp. 1-10.
[DOI][Pmid][serval:BIB_4AC480849F5B]
Sex differences in the occurrence and reporting of adverse drug reactions in hypertension: What are the clinical implications?
Burnier M., 2022. Kardiologia polska, 80 (11) pp. 1065-1067. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AC88963183B4]
Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action.
Bandiera C., Ribaut J., Dima A.L., Allemann S.S., Molesworth K., Kalumiya K., Käser F., Olson M.S., Burnier M., van Boven JFM et al., 2022. International journal of public health, 67 p. 1605204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9A9F2371DDD2]
 
The impact of stenting prior to oral chemolysis of upper urinary tract uric acid stones.
Tsaturyan A., Bosshard P., Bokova E., Bonny O., Stritt K., Roth B., 2022/01. International urology and nephrology, 54 (1) pp. 37-45. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9CB5BA7F3459]
Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.
Zanchi A., Pruijm M., Muller M.E., Ghajarzadeh-Wurzner A., Maillard M., Dufour N., Bonny O., Wuerzner G., Burnier M., 2022. Frontiers in cardiovascular medicine, 9 p. 854230. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6281EA6B3D3F]
2021
 
Is modifying salt intake an effective treatment strategy for hypertension control?
Burnier M., 2021/12/31. Nephrology, dialysis, transplantation, 37 (1) pp. 31-32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22547EEFD8F2]
 
Salt-Sensitive Hypertension in GR<sup>+/-</sup> Rats Is Accompanied with Dysregulation in Adrenal Soluble Epoxide Hydrolase and Polyunsaturated Fatty Acid Pathways.
Vanderriele P.E., Wang Q., Mérillat A.M., Ino F., Aeschlimann G., Ehret X., Ancin Del Olmo D., Ponce de León V., Scholl U.I., Winter D.V. et al., 2021/12/08. International journal of molecular sciences, 22 (24) p. 13218. Peer-reviewed.
[DOI][Pmid][serval:BIB_D4AAC3B8BC3F]
 
Global warming applied to dialysis: facts and figures.
Burnier M., Fouque D., 2021/12/02. Nephrology, dialysis, transplantation, 36 (12) pp. 2167-2169. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21F8A4271CBD]
 
Assessment of a strategy combining ambulatory blood pressure, adherence monitoring and a standardised triple therapy in resistant hypertension.
Polychronopoulou E., Burnier M., Ehret G., Schoenenberger-Berzins R., Berney M., Ponte B., Erne P., Bochud M., Pechère-Bertschi A., Wuerzner G., 2021/12. Blood pressure, 30 (6) pp. 332-340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5FFCC4F2CB0]
Glycine increases fat-free mass in malnourished haemodialysis patients: a randomized double-blind crossover trial.
Genton L., Teta D., Pruijm M., Stoermann C., Marangon N., Mareschal J., Bassi I., Wurzner-Ghajarzadeh A., Lazarevic V., Cynober L. et al., 2021/12. Journal of cachexia, sarcopenia and muscle, 12 (6) pp. 1540-1552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EAE5DFBD60B7]
 
Gut barrier and microbiota changes with glycine and branched-chain amino acid supplementation in chronic haemodialysis patients.
Genton L., Pruijm M., Teta D., Bassi I., Cani P.D., Gaïa N., Herrmann F.R., Marangon N., Mareschal J., Muccioli G.G. et al., 2021/12. Journal of cachexia, sarcopenia and muscle, 12 (6) pp. 1527-1539. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_93DD589D4F0E]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University